Schrijvers DM, De Meyer GR, Kockx MM, Herman AG, Martinet W
Who Benefits From Each Approach: Clinical Context and Safety Considerations Berberine may appeal to patients seeking a natural, over-the-counter option with minimal regulatory oversight and relatively low cost
Weight comes back after stopping: in the STEP 1 extension, people regained about two-thirds of their lost weight within a year of stopping (Wilding and colleagues, Diabetes, Obesity and Metabolism , 2022)
10.1515/bchm3.1996.377.9.555 377 LonghiS.UverskyV
The Role of GLP-1 Agonists Despite the rising burden of obesity-related illnessesranging from diabetes and cardiovascular diseases to metabolic disorderseffective pharmacological treatments like Ozempic remain out of reach for most Indians due to their prohibitive costs